Resource Center
Resource Center
Unitaid, the Clinton Health Access Initiative, and Laurus Labs announce agreement to accelerate development of best-in-class second- and third-line HIV medication for children.
Read moreA CHAI-supported study published in AIDS describes pilot programs in Malawi and Zimbabwe to integrate TB and HIV testing on the same near-point-of-care devices within facilities.
Read moreCHAI and partners' study published in the journal of HIV Medicine looks at whether clients were less likely to keep to their appointment schedules under the Eswatini treat all policy.
Read moreUnitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV.
Read moreA full list of sessions that CHAI is participating in at the Internationl AIDS Society conference.
Read moreCHAI presents cost-effectiveness modeling framework at IAS 2021 to understand the role of multipurpose prevention technologies in HIV prevention and family planning.
Read moreCHAI interviewed individuals who are at high risk of contracting HIV in South Africa to understand their experiences with facilities that initiated them on PrEP and the factors that helped them adhere to treatment.
Read moreCHAI invited an adolescent, a caregiver, and a healthcare provider to share their experiences of HIV in South Africa to better inform future policy.
Read moreIntroducing the fifth edition of CHAI’s HIV Mid-Year Market Memo, a brief that covers the latest trends in the HIV space in low- and middle-income countries since the publication of CHAI’s annual HIV Market Report in September 2020.
Read moreThe Southern African Journal of HIV Medicine has published a CHAI-led study reflecting on the progress South Africa has made towards eliminating HIV.
Read more